Quanterix Corporation is developing a novel platform for single molecule analysis that will bring an unprecedented level of sensitivity, precision, and assay robustness to clinical diagnostics, drug development, and life science research.
The revolutionary technology of QuantomiX solves the problem of preparing wet samples for high-resolution imaging. It closes the resolution gap between conventional electron microscopy and light microscopy and offers the convenient sample preparation of light microscopy.
Quantum Corporation (QCorp) is the parent company of group of companies, head quartered in Bangalore, India. QCorp was established in 2007 with a vision to create world class Nanomaterials and Nanocomposites with strong Intellectual Property that are changing the properties of products across the globe. QCorp has developed high quality Smart Polymers, Nanomaterials and Nanocomposites as core materials for manufacturers in Telecommunications, Electronics, Drug Delivery, Conductive films, Lighting and Energy industries - without the need to change their existing processes.
Quantum Materials Corporation (QMC) is now commercializing a low cost quantum dot technology of a superior quality and characteristics. This revolutionary new quantum dot production technique, developed by Dr. Michael S. Wong and colleagues of William Marsh Rice University, Houston, TX., has been acquired under an exclusive, world-wide license. Our new synthesis method is mass producible using continuous flow technology processes developed in conjunction with Access2Flow microreactor technology. QMC's research and development group was instrumental in developing the new scaling-up process.
The Quantum Valley Investment Fund will provide commercialization funding, expertise and support for researchers that develop breakthroughs in Quantum Information Science that can reasonably lead to new commercializable technologies and applications.
Quantum14 Corp. is dedicated to develop and commercialize 'Porous Silicon' technology which is based on the anodization technique for creating porous silicon with prescribed pore sizes ranging from nanometer to macroscopic scales.
QuantumBio, Inc is accelerating the drug discovery efforts by providing pharmaceutical, biotechnology companies and life science research organizations a next generation of Computer-Assisted Molecular Modeling (CAMM) and Computer-Assisted Drug Design (CADD) solutions.
QuantumWise produces software for atomic-scale modeling of nanoelectronic devices, wrapped in a platform with a graphical user interface and a scripting language interface. The company is unique in offering a commercial code that can do transport calculations using first-principles methods, and at the same time the back-end provides state-of-the-art simulation capacity for large-scale systems, allowing for systems with over 1,000 atoms to be simulated on a single workstation.
The initial product offering from Quickshot XRF focuses on two main applications; precious metal analysis and hazardous substance detection. Additional instruments and software packages are in development to provide low-cost options to organizations that require accurate coating thickness measurements and alloy verification.
Quickstep, or more specifically, the Quickstep Process, is a range of unique and patented technologies that can be used in the out-of-autoclave manufacture of advanced composite materials, including nanocomposite production.
Development and commercialization of next generation quantum nanoscale semiconductor materials and devices for the electronics, optoelectronics and sensor markets based on the company's proprietary heterostructured nanowire epitaxial growth and process technologies.
The company manufactures Demron&trade, a material constructed from a unique nanotechnology that far surpasses the effectiveness of current nuclear-biological-chemical suits that only protect against radioactive particulate sources.